National Hospital for Neurology and Neurosurgery Development Foundation

The Foundation funds a wide range of neurological disorders including stroke, brain tumours, dementia, epilepsy, Parkinson's disease, multiple sclerosis, neuro-rehabilitation and rare neurological conditions. Supported activities include clinical trials, medical technologies, neuro-intensive care, specialist wards, diagnostic innovations, training programmes for neurology leaders and capital projects that enable rapid therapy translation. The Foundation champions translational research, patient-centred clinical services and preventative neuro-rehabilitation. All funded work is based in London, centred on the Queen Square area, with a focus on NHS clinical departments and university research units delivering national-scale impact.

The Foundation welcomes applications from NHS clinical departments, university research units and scientists based at or affiliated with the National Hospital for Neurology and Neurosurgery and UCL Queen Square Institute of Neurology. Beneficiaries include adults and children affected by neurological and neuromuscular conditions, as well as their families. The Foundation prioritises collaborative, evidence-based initiatives that demonstrate potential for step-change impact. Unsolicited applications are accepted, and the Foundation encourages approaches that align with its focus on innovation and clinical excellence.

The Foundation does not fund core costs, unrestricted grants, emergency relief or non-transformative incremental projects. It avoids generalist health initiatives outside the field of neurology. Projects that do not demonstrate a clear link to the Foundation's mission of advancing neurological care through research and treatment are unlikely to be supported.

The Foundation provides project-specific grants for targeted interventions, including capital projects, clinical trials and medical technologies. It favours collaborative, evidence-based initiatives that accelerate scientific translation into patient therapies. The Foundation welcomes unsolicited applications and works closely with its partner institutions to identify and support high-impact opportunities. Funding is typically directed towards step-change advancements rather than ongoing operational costs.